Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 49.60
+0.32 (0.65%)
At close: Sep 30, 2025
Sunshine Lake Pharma Revenue
In the year 2024, Sunshine Lake Pharma had annual revenue of 3.72B CNY, down -40.84%. Sunshine Lake Pharma had revenue of 1.27B in the half year ending December 31, 2024, a decrease of -48.24%.
Revenue
3.72B CNY
Revenue Growth
-40.84%
P/S Ratio
7.22
Revenue / Employee
766.05K CNY
Employees
4,861
Market Cap
28.60B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.72B | -2.57B | -40.84% |
| Dec 31, 2023 | 6.29B | 2.55B | 68.08% |
| Dec 31, 2022 | 3.74B | 2.83B | 309.83% |
| Dec 31, 2021 | 913.79M | -1.43B | -61.08% |
| Dec 31, 2020 | 2.35B | -3.88B | -62.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |